CHOICE says products which have not been tested also needs to be marked. See to find out more.. Calls for tougher rules on complementary medicines in Australia Pressure from a customer group offers prompted the Australian AUTHORITIES to consider the intro of a lot more stringent disclosure guidelines regarding complementary medications. The consumer group CHOICE has needed tougher regulation of the sector in order to protect consumers. CHOICE says complementary medications make many statements about their product’s efficiency which often haven’t any evident basis and in some cases, complementary medicines can harm consumers’ health and current regulatory action does not do enough to protect consumers.Frank Laukien, PhD, President and CEO of Bruker Corporation, added: We are excited to have Alexander Sasov and his capable SkyScan team join us, adding in-depth 3D X-ray micro-CT imaging encounter to Bruker. We are impressed by the portfolio of high-performance SkyScan products which fit nicely into our global components research and preclinical imaging distribution stations, and which complement our additional X-ray analysis and preclinical MRI items. The Bruker microCT group shares our philosophy of innovation, customer and quality support excellence.